Status:

COMPLETED

Imaging Airway Liquid Absorption in Cystic Fibrosis

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institutes of Health (NIH)

National Heart, Lung, and Blood Institute (NHLBI)

Conditions:

Cystic Fibrosis

Eligibility:

All Genders

6+ years

Phase:

NA

Brief Summary

The investigators are developing a new nuclear medicine imaging technique for measuring liquid absorption in the airways that can be applied to screen new medications being developed to treat cystic f...

Detailed Description

The investigators have recently developed a novel aerosol-based imaging technique to detect changes in liquid absorption in the airways - a central pathophysiological process known to be important in ...

Eligibility Criteria

Inclusion

  • Adult healthy control arm:
  • subjects 18 years old or older without a diagnosis of lung disease.
  • Pediatric CF arm:
  • subjects 6-14 years with a diagnosis of cystic fibrosis as determined by sweat test or genotype
  • subjects who are clinically stable as determined by the pediatrician co-investigator
  • subjects must have a previously demonstrated ability to perform reproducible pulmonary function testing based on previous clinical visits.
  • Females in all groups who are of child-bearing potential will need to have a negative urine pregnancy test.

Exclusion

  • Adult healthy control arm:
  • FEV1%p \< 80% of predicted
  • nursing mother
  • positive urine pregnancy test or unwilling to test
  • cigarette smoker (regular smoking within 6 months of study).
  • Pediatric CF arm:
  • FEV1%p \< 40% of predicted
  • nursing mother
  • positive urine pregnancy test for females of childbearing potential
  • unable or unwilling to comply with test procedure
  • cigarette smoker (regular smoking within 6 months of study).
  • Subjects unable to lie recumbent without moving for the 80 minute imaging period will be excluded.

Key Trial Info

Start Date :

October 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2014

Estimated Enrollment :

20 Patients enrolled

Trial Details

Trial ID

NCT01486199

Start Date

October 1 2011

End Date

October 1 2014

Last Update

September 25 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pittsburgh

Pittsburgh, Pennsylvania, United States, 15213